PubMed:33122196 / 621-800 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":40,"end":47},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Surprisingly, SARS-CoV-2 trimeric spike protein increased ACE2 proteolytic activity ~3-10 fold against model peptide substrates, such as caspase-1 substrate and Bradykinin-analog."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T6","span":{"begin":14,"end":22},"obj":"Disease"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Surprisingly, SARS-CoV-2 trimeric spike protein increased ACE2 proteolytic activity ~3-10 fold against model peptide substrates, such as caspase-1 substrate and Bradykinin-analog."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":75,"end":83},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T8","span":{"begin":109,"end":116},"obj":"http://purl.obolibrary.org/obo/PR_000018263"}],"text":"Surprisingly, SARS-CoV-2 trimeric spike protein increased ACE2 proteolytic activity ~3-10 fold against model peptide substrates, such as caspase-1 substrate and Bradykinin-analog."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9","span":{"begin":40,"end":47},"obj":"Chemical"},{"id":"T10","span":{"begin":109,"end":116},"obj":"Chemical"}],"attributes":[{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"Surprisingly, SARS-CoV-2 trimeric spike protein increased ACE2 proteolytic activity ~3-10 fold against model peptide substrates, such as caspase-1 substrate and Bradykinin-analog."}

{"project":"LitCovid-PubTator","denotations":[{"id":"42","span":{"begin":14,"end":24},"obj":"Species"},{"id":"43","span":{"begin":34,"end":39},"obj":"Gene"},{"id":"44","span":{"begin":58,"end":62},"obj":"Gene"},{"id":"45","span":{"begin":137,"end":146},"obj":"Gene"},{"id":"46","span":{"begin":161,"end":171},"obj":"Gene"}],"attributes":[{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"Tax:2697049"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"Gene:43740568"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"Gene:59272"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"Gene:834"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"Gene:3827"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Surprisingly, SARS-CoV-2 trimeric spike protein increased ACE2 proteolytic activity ~3-10 fold against model peptide substrates, such as caspase-1 substrate and Bradykinin-analog."}

{"project":"LitCovid-sentences","denotations":[{"id":"T6","span":{"begin":0,"end":179},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Surprisingly, SARS-CoV-2 trimeric spike protein increased ACE2 proteolytic activity ~3-10 fold against model peptide substrates, such as caspase-1 substrate and Bradykinin-analog."}

{"project":"LitCovid_AGAC_only","denotations":[{"id":"p261846s10","span":{"begin":48,"end":57},"obj":"PosReg"},{"id":"p261846s11","span":{"begin":58,"end":83},"obj":"MPA"}],"text":"Surprisingly, SARS-CoV-2 trimeric spike protein increased ACE2 proteolytic activity ~3-10 fold against model peptide substrates, such as caspase-1 substrate and Bradykinin-analog."}

{"project":"sentences","denotations":[{"id":"T6","span":{"begin":0,"end":179},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Surprisingly, SARS-CoV-2 trimeric spike protein increased ACE2 proteolytic activity ~3-10 fold against model peptide substrates, such as caspase-1 substrate and Bradykinin-analog."}

{"project":"mondo_disease","denotations":[{"id":"T6","span":{"begin":14,"end":24},"obj":"Disease"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Surprisingly, SARS-CoV-2 trimeric spike protein increased ACE2 proteolytic activity ~3-10 fold against model peptide substrates, such as caspase-1 substrate and Bradykinin-analog."}

{"project":"NCBITAXON","denotations":[{"id":"T7","span":{"begin":14,"end":22},"obj":"OrganismTaxon"}],"attributes":[{"id":"A7","pred":"db_id","subj":"T7","obj":"694009"}],"text":"Surprisingly, SARS-CoV-2 trimeric spike protein increased ACE2 proteolytic activity ~3-10 fold against model peptide substrates, such as caspase-1 substrate and Bradykinin-analog."}